Creating and providing important tools for research on lymphatic filariasis.
PRODUCTION AND DISTRIBUTION OF FILARIAL RESEARCH REAGENTS DATA
['FUNDING_OTHER'] · UNIVERSITY OF GEORGIA · NIH-11308529
This study is all about making important tools for labs in the U.S. that are working on finding better ways to treat and prevent lymphatic filariasis, a disease caused by parasitic worms, so that patients can eventually benefit from new treatments.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF GEORGIA (nih funded) |
| Locations | 1 site (ATHENS, UNITED STATES) |
| Trial ID | NIH-11308529 on ClinicalTrials.gov |
What this research studies
This research focuses on producing and supplying essential reagents that are crucial for laboratories in the U.S. that are investigating lymphatic filariasis, a disease caused by parasitic worms. By providing these reagents, the project aims to support the development of medical countermeasures to combat this condition. Patients may benefit indirectly as the research could lead to new treatments or preventive measures against lymphatic filariasis. The approach involves collaboration with various research institutions to ensure that the reagents meet the necessary standards for effective research.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research are individuals affected by lymphatic filariasis or those at risk of contracting the disease.
Not a fit: Patients who do not have lymphatic filariasis or are not at risk for the disease may not receive any direct benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments or preventive measures for lymphatic filariasis, improving patient outcomes.
How similar studies have performed: Other research has shown success in developing medical countermeasures for parasitic diseases, indicating that this approach has potential.
Where this research is happening
ATHENS, UNITED STATES
- UNIVERSITY OF GEORGIA — ATHENS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GUPTA, TUHINA — UNIVERSITY OF GEORGIA
- Study coordinator: GUPTA, TUHINA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.